239,613 Shares in Waters Corporation $WAT Bought by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Waters Corporation (NYSE:WAT) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 239,613 shares of the medical instruments supplier’s stock, valued at approximately $89,864,000. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.24% of Waters as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of WAT. Zions Bancorporation National Association UT raised its stake in shares of Waters by 121.2% in the fourth quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock worth $28,000 after buying an additional 40 shares during the period. SHP Wealth Management bought a new position in shares of Waters during the 4th quarter valued at approximately $32,000. DV Equities LLC bought a new position in shares of Waters during the 4th quarter valued at approximately $32,000. Anchor Investment Management LLC purchased a new stake in Waters in the 1st quarter worth approximately $27,000. Finally, Resources Management Corp CT ADV purchased a new stake in Waters in the 1st quarter worth approximately $27,000. Institutional investors own 94.01% of the company’s stock.

Insider Buying and Selling at Waters

In related news, Director Christopher A. Kuebler sold 3,626 shares of the firm’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the completion of the transaction, the director directly owned 17,808 shares of the company’s stock, valued at approximately $7,086,515.52. This trade represents a 16.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.31% of the company’s stock.

Analysts Set New Price Targets

WAT has been the topic of a number of recent analyst reports. TD Cowen upgraded shares of Waters from a “hold” rating to a “buy” rating and raised their target price for the stock from $408.00 to $475.00 in a research note on Wednesday, August 5th. JPMorgan Chase & Co. increased their price objective on shares of Waters from $330.00 to $345.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Bank of America raised their price objective on shares of Waters from $370.00 to $400.00 and gave the company a “neutral” rating in a research report on Tuesday, June 2nd. The Goldman Sachs Group lifted their target price on shares of Waters from $380.00 to $425.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Finally, Sanford C. Bernstein started coverage on shares of Waters in a report on Friday, June 26th. They issued an “outperform” rating and a $435.00 target price for the company. Three investment analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $420.35.

Waters Stock Down 1.5%

NYSE WAT opened at $401.78 on Wednesday. The stock’s 50 day moving average is $378.68 and its 200 day moving average is $346.24. The company has a current ratio of 1.86, a quick ratio of 1.29 and a debt-to-equity ratio of 0.32. Waters Corporation has a 12 month low of $282.77 and a 12 month high of $420.26. The stock has a market cap of $39.47 billion, a PE ratio of 100.19, a P/E/G ratio of 2.40 and a beta of 1.19.

Waters (NYSE:WAT) last announced its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.01 by $0.04. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.62 billion. Waters had a net margin of 3.58% and a return on equity of 11.27%. The company’s revenue was up 113.3% on a year-over-year basis. During the same period last year, the firm posted $2.95 EPS. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Research analysts predict that Waters Corporation will post 14.57 EPS for the current fiscal year.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.